Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Pharm Des. 2012;18(25):3670-6.

Permeating the blood brain barrier and abrogating the inflammation in stroke: implications for stroke therapy.

Author information

  • 1Department of Neurology, Georgia Health Sciences University, Augusta, Georgia 30912, USA. cborlong@health.usf.edu

Abstract

Cell therapy has been shown as a potential treatment for stroke and other neurological disorders. Human umbilical cord blood (HUCB) may be a promising source of stem cells for cell therapy. The most desired outcomes occur when stem cells cross the blood brain barrier (BBB) and eventually reach the injured brain site. We propose, from our previous studies, that mannitol is capable of disrupting the BBB, allowing the transplanted cells to enter the brain from the periphery. However, when the BBB is compromised, the inflammatory response from circulation may also be able to penetrate the brain and thus may actually exacerbate the stroke rather than afford therapeutic effects. We discuss how an NF-kB decoy can inhibit the inflammatory responses in the stroke brain thereby reducing the negative effects associated with BBB disruption. In this review, we propose the combination of mannitol-induced BBB permeation and NF-kB decoy for enhancing the therapeutic benefits of cell therapy in stroke.

PMID:
22574981
[PubMed - indexed for MEDLINE]
PMCID:
PMC3411920
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Bentham Science Publishers Ltd. Icon for PubMed Central
    Loading ...
    Write to the Help Desk